Since the earliest medical records were kept, cancer as a disease has been described in the history of medicine.
The earliest known descriptions of cancer appear in seven papyri, discovered and deciphered late in the 19th century. They provided the first direct knowledge of Egyptian medical practice. Two of them, known as the "Edwin Smith" and "George Ebers" papyri, contain descriptions of cancer written around B.
The Smith papyrus describes surgery , while the Ebers' papyrus outlines pharmacological, mechanical, and magical treatments. Based on the information recorded on papyri and hieroglyphic inscriptions, ancient Egyptians were able to distinguish benign tumors from malignant tumors.
They were also able to use different treatments, including surgery, and other various modes of medicine. Following the decline of Egypt, the next chapters of medical and scientific history were written in Greece and Rome. The great doctors Hippocrates and Galen dominated medical thought for years. They lifted medicine out of the realms of magic, superstition, and religion.
Hippocrates and Galen defined disease as a natural process , and based treatment on observation and experience. Photo source: PixaBay. Amy Loriaux. I currently work at a small CRO involved in clinical trial management. AUG 19, A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was Written By: Annie Lennon. AUG 23, Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m Written By: Katie Kokolus.
SEP 16, Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old. Estimates for OCT 10, There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus Written By: Carmen Leitch. OCT 25, Today, we are able to cure some types of cancer, and research is ongoing. Clinical trials and research studies are the key to finding a cure, or a definitive method of prevention.
Limiting processed foods and red meats can help ward off cancer risk. These recipes focus on antioxidant-rich foods to better protect you and your loved ones. Sign up and get your guide! Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer. Ann Surg Oncol. Cancer: we should not forget the past. J Cancer. Published Jan 1. Faguet GB. A brief history of cancer: age-old milestones underlying our current knowledge database. Int J Cancer. American Cancer Society. Early theories about cancer causes.
Updated June 12, Williamson AK. The conscientious autopsy. Autops Case Rep. Published Jul 3. It is the first and so far only human cancer treatment vaccine to be approved. FDA approves the use of ipilimumab, a monoclonal antibody, for the treatment of inoperable or metastatic melanoma. Ipilimumab stimulates the immune system to attack cancer cells by removing a "brake" that normally controls the intensity of immune responses.
Results of the NCI-sponsored PLCO Cancer Screening Trial confirm that screening people 55 years of age and older for colorectal cancer using flexible sigmoidoscopy reduces colorectal cancer incidence and mortality. T-DM1 is an immunotoxin an antibody-drug conjugate that is made by chemically linking the monoclonal antibody trastuzumab to the cytotoxic agent mertansine, which inhibits cell proliferation by blocking the formation of microtubules. Researchers from The Cancer Genome Atlas TCGA project, a joint effort by NCI and the National Human Genome Research Institute to analyze the DNA and other molecular changes in more than 30 types of human cancer, find that gastric stomach cancer is actually four different diseases, not just one, based on differing tumor characteristics.
This finding from TCGA and other related projects may potentially lead to a new classification system for cancer, in which cancers are classified by their molecular abnormalities as well as their organ or tissue site of origin. FDA approves pembrolizumab for the treatment of advanced melanoma.
This monoclonal antibody blocks the activity of a protein called PD1 on immune cells, which increases the strength of immune responses against cancer. The study is designed to determine whether targeted therapies for people whose tumors have specific gene mutations will be effective regardless of their cancer type.
FDA approves talimogene laherparepvec T-VEC for the treatment of some patients with metastatic melanoma that cannot be surgically removed. T-VEC, the first oncolytic virus approved for clinical use, works by infecting and killing tumor cells and stimulating an immune response against cancer cells throughout the body. Congress passes the 21st Century Cures Act, which provides funding for the Cancer Moonshot, a broad program to accelerate cancer research by investing in specific research initiatives that have the potential to transform cancer care, detection, and prevention.
FDA approves tisagenlecleucel to treat a form of acute lymphoblastic leukemia in certain children and young adults. FDA subsequently approves axicabtagene ciloleucel for patients with large B-cell lymphomas whose cancer has progressed after receiving at least two prior treatment regimens. Both treatments are chimeric antigen receptor CAR T-cell therapies that are personalized for each patient.
To create these therapies, T cells are removed from the patient, genetically altered to recognize cancer-specific antigens, grown to large numbers in the lab, and then infused back into the patient to stimulate their immune system to attack cancer cells.
FDA extends approval of pembrolizumab to treat metastatic and inoperable solid tumors that have certain genetic changes, wherever they occur in the body , that have progressed following prior treatment and that have no alternative treatment options. FDA clears two products to test tumors for genetic changes that may make the tumors susceptible to treatment with FDA-approved molecularly targeted drugs.
The FoundationOne test serves as a companion diagnostic for several FDA-approved drugs targeting five common types of cancer. The PanCancer Atlas provides a detailed genomic analysis of molecular and clinical data from more than 10, tumors that gives cancer researchers an unprecedented understanding of how, where, and why tumors arise in humans. It is one of the first trials to examine a way to personalize cancer treatment.
The approval is for pediatric or adult patients with metastatic or inoperable solid tumors that have worsened after previous treatment anywhere in the body driven by an NTRK gene fusion without a known acquired resistance mutation. Larotrectinib is the second drug approved to treat cancer with specific molecular features regardless of where the cancer is located.
A consortium of international researchers analyzes more than 2, whole genomes from 38 types of cancer and matching normal tissues to identify common patterns of molecular changes. The Pan-Cancer Analysis of Whole Genomes study, which used data collected by the International Cancer Genome Consortium and TCGA, uncovers the complex role that changes throughout the genome play in cancer development, growth, and spread.
The study also extends genomic analyses of cancer beyond the protein-coding regions to the complete genetic composition of cells. Menu Contact Dictionary Search. Understanding Cancer. What Is Cancer?
Cancer Statistics. Cancer Disparities. Cancer Causes and Prevention. Risk Factors. Cancer Prevention Overview. Cancer Screening Overview. Screening Tests. Diagnosis and Staging. Questions to Ask about Your Diagnosis. Types of Cancer Treatment. Side Effects of Cancer Treatment. Clinical Trials Information. A to Z List of Cancer Drugs.
Questions to Ask about Your Treatment. Feelings and Cancer. Adjusting to Cancer. Day-to-Day Life. Support for Caregivers. Questions to Ask About Cancer.
Choices for Care. Talking about Your Advanced Cancer.
0コメント